← Sabra Health Care REIT, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $260.5m |
$405.6m
+55.70%
|
$623.4m
+53.68%
|
$128.1m
-79.46%
|
$156.0m
+21.85%
|
$155.5m
-0.34%
|
$186.7m
+20.04%
|
$647.5m
+246.87%
|
$703.2m
+8.61%
|
$774.6m
+10.15%
|
$859.6m
+10.96%
|
|
| Gains (Losses) on Sales of Investment Real Estate | ($6.1m) | $52.0m | $128.2m | $2.3m | $2.9m | $12.3m | ($12.0m) | ($76.6m) | $2.1m | ($3.5m) | — | |
| General and Administrative Expense | $19.9m | $32.4m | $36.5m | $30.5m | $32.8m | $34.7m | $39.6m | $47.5m | $50.1m | $53.7m | $60.1m | |
| Amortization of Intangible Assets | — | — | — | — | — | $8.7m | $17.6m | $11.6m | $7.5m | $19.1m | — | |
| Operating Lease, Lease Income | — | — | — | $452.1m | $430.6m | $396.7m | $400.6m | $376.3m | $381.5m | $374.1m | — | |
| Operating Lease, Expense | — | — | — | — | — | — | — | $1.4m | $1.3m | $1.0m | — | |
| Operating expenses: | ||||||||||||
| Other Operating Income (Expense), Net | $10.7m | $3.2m | $4.5m | $2.1m | $2.2m | $373k | ($1.1m) | $2.6m | $2.7m | $14.0m | — | |
| Interest Expense, Debt | $64.9m | $88.4m | $147.1m | $126.6m | $100.4m | $98.6m | $105.5m | $113.0m | $115.3m | $112.5m | $116.0m | |
| Other Nonoperating Income (Expense) | — | $54.6m | $129.8m | ($11.9m) | $4.5m | ($21.9m) | ($13.5m) | ($75.6m) | $4.8m | $9.4m | — | |
| Income (Loss) from Equity Method Investments | — | — | ($5.4m) | ($6.8m) | ($16.6m) | ($28.0m) | ($40.3m) | ($2.9m) | ($397k) | $3.9m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | $159.0m | $287.6m | $79.2m | $155.7m | — | — | — | — | — | $67.4m | |
| Income Tax Expense (Benefit) | — | $651k | $3.0m | $3.4m | $710k | $1.8m | $1.2m | $2.0m | $1.0m | $1.8m | $2.1m | |
| Net Income (Loss) Attributable to Parent | $70.3m |
$158.4m
+125.37%
|
$279.1m
+76.21%
|
$69.0m
-75.28%
|
$138.4m
+100.62%
|
($113.3m)
-181.82%
|
($77.6m)
+31.48%
|
$13.8m
+117.73%
|
$126.7m
+821.14%
|
$155.6m
+22.81%
|
$65.4m
-57.95%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | $60.0m |
$148.1m
+146.76%
|
$269.3m
+81.80%
|
$69.0m
-74.38%
|
$138.4m
+100.62%
|
— | — | — | — | — | $65.4m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | ($71k) | ($18k) | $33k | $22k | $0 | $0 | — | — | — | ($99k) | $65.4m | |
| Preferred Stock Dividends, Income Statement Impact | $10.2m | $10.2m | $9.8m | $0 | $0 | — | — | — | — | — | — | |
| Earnings Per Share, Basic | $0.92 | $1.40 | $1.51 | $0.37 | $0.67 | ($0.52) | ($0.34) | $0.06 | $0.54 | $0.64 | $0.26 | |
| Earnings Per Share, Diluted | $0.92 | $1.40 | $1.51 | $0.37 | $0.67 | ($0.52) | ($0.34) | $0.06 | $0.54 | $0.64 | $0.26 | |
| Common Stock, Dividends, Per Share, Declared | $1.67 | $1.73 | $1.80 | $1.80 | $1.35 | $1.20 | $1.20 | $1.20 | $1.20 | $1.20 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 65.3m | 105.6m | 178.3m | 187.2m | 206.2m | 219.1m | 230.9m | 231.2m | 233.5m | 241.3m | 248.4m | |
| Weighted Average Number of Shares Outstanding, Diluted | 65.5m | 105.8m | 178.7m | 188.1m | 207.3m | 219.1m | 230.9m | 232.8m | 236.0m | 244.5m | 252.0m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | $1.2m | $30.3m | $636k | $424k | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $70.2m | $158.4m | $279.1m | $69.0m | $138.4m | — | — | — | — | — | — |